ADRX Private
ADRX is a drug discovery platform that transforms atomic structures into small molecule therapies. Using proprietary structure-based technology, they are developing small molecule disaggregators and inhibitors that target previously unreachable misfolded proteins in neurodegenerative diseases. Tau, TDP-43, and alpha-synuclein programs are in its pipeline. Capability to identify, design, and develop therapeutics for pathological protein structures derived from patients
Industry:
PharmTech
Last Funding Date:
2020-10-13
Technology:
Medical Devices
Last Funding Type:
Venture - Series Unknown
Headquarters:
Thousand Oaks, California, United States
Founded Date:
2013
Total Funding:
$24 256 198
Employee Number:
1-10